Work

1365P The impact of PSMA-positive circulating tumor cells in men with metastatic castrate-resistant prostate cancer (mCRPC)

Year: 2022

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2022.07.1497

Authors: S. Gupta, Q. Yang, S. Halabi, A. Tubbs, Y. Gore, D.J. George, D.M. Nanus, E.S. Antonarakis, D. Danila, R. Szmulewitz, R.J. Wenstrup, A.J. Armstrong

Institutions: Epic Sciences (United States), Duke Medical Center, Duke University Health System, Weill Cornell Medicine, Johns Hopkins University, Memorial Sloan Kettering Cancer Center, University of Chicago, University of Chicago Medical Center, Duke University, Duke Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4295836746

FWCI: 0.087

Cites:

Cited by: 1

Related to: 10